0002-1717-28 : NDC 2026 Code

0002-1717-28 : Imlunestrant ( Inluriyo )

Additionally :

You can get information about “0002-1717-28” NDC code in 0002-1717-28 in HTML format

HTML | 0002-1717-28 in TXT (Plain Text) format

TXT | 0002-1717-28 in PDF (Portable Document Format)

PDF | 0002-1717-28 in XML format

XML formats.

NDC Code : 0002-1717-28 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "0002-1717-28",
    "PackageDescription": "28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28) ",
    "NDC11Code": "00002-1717-28",
    "ProductNDC": "0002-1717",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Inluriyo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Imlunestrant",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250925",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA218881",
    "LabelerName": "Eli Lilly and Company",
    "SubstanceName": "IMLUNESTRANT",
    "StrengthNumber": "200",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-02-25",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20251016",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}